Clinical trial Recruiting at 9 sites Interventional Ages 18 and up

NIRS for EDResp: Which first helps hypoxemic adults best?

Official title: WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

Run by Ohio State University · NCT07558265 · Data updated 2026-11-12

This trial tests whether non-invasive ventilation with a mask (NIPPV) or high-flow nasal oxygen (HFNO) is more helpful for adults in the emergency department with acute hypoxemic respiratory failure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorOhio State University
Academic / other
Locations9 sites (Tucson, Arizona and 8 other locations)
StatusRecruiting
StartedAugust 18, 2026
Main results expectedAugust 2031
Study endsAugust 2031
Registry record updatedNovember 5, 2026
Trial IDNCT07558265 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older presenting to the ED with acute hypoxemic respiratory failure requiring non-invasive respiratory support.

Probably not a fit

Patients who rapidly deteriorate requiring immediate intubation or who have contraindications to either NIPPV or HFNO may not benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this multicenter trial, adults presenting to the ED with acute hypoxemic respiratory failure are randomly assigned to receive either non-invasive positive pressure ventilation or high-flow nasal oxygen as the initial respiratory support. The study focuses on clinically important outcomes such as survival, need for invasive mechanical ventilation, and duration of respiratory support during hospitalization. Participants are enrolled within hours of identifying the need for non-invasive respiratory support and are treated with the assigned modality to determine which approach yields better patient outcomes in the ED setting. The WINDSURFER trial aims to clarify the optimal first-line non-invasive strategy for undifferentiated AHRF in real-world emergency department practice.

Why it matters

Potential benefit: If successful, the trial could identify a preferred initial non-invasive strategy, potentially improving survival and reducing invasive ventilation needs for ED patients with AHRF.

How similar studies have gone: Prior studies are limited and mostly in ICU settings; this ED-focused comparison is relatively novel but builds on existing NIRS evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Presenting to the Emergency Department (ED) with Acute Hypoxemic Respiratory failure (AHRF), defined as:

  * \[(respiratory rate ≥25 breaths/min) AND (requiring ≥6 L/min of oxygen required to maintain SpO2 ≥90%), OR SpO2:FiO2 ratio\<250\] OR
  * Arrival at ED on prehospital Non-Invasive Respiratory Support (NIRS).
* Clinical need for NIRS
* Randomization ≤2 hours after identification of need for NIRS
* Randomization ≤6 hours of ED arrival

Exclusion Criteria:

* Urgent need for intubation
* Cardiac arrest
* Respiratory arrest
* Patient not located in the ED
* Craniofacial anatomic features that prohibit either Non-Invasive Positive Pressure Ventilation (NIPPV) or High Flow Nasal Oxygen (HFNO) interface
* Tracheostomy or laryngectomy stoma
* Hemodynamic instability requiring \>0.2mcg/kg/min of norepinepherine (or equivalent) to maintain mean arterial pressure \>65mmHg
* Pre-existing "do not resuscitate" or "do not intubate" order
* Home use of non-invasive positive-pressure ventilation for respiratory support of a medical condition other than sleep apnea
* Transferred from another Emergency Department
* History of advanced chronic obstructive pulmonary disease
* History of advanced heart failure
* Presence of opt-out identification
* Prisoner
* Known or apparent pregnant
* Previous enrollment in WINDSURFER
* A patient-specific contraindication makes one assigned study intervention unsafe

Where it's running

  • Banner University Medical Center Tucson
    Tucson, Arizona, United States
    Recruiting
  • Yale New Haven Hospital
    New Haven, Connecticut, United States
    Recruiting
  • University of Michigan Medical Center
    Ann Arbor, Michigan, United States
    Recruiting
  • Wake Forest Baptist Medical Center
    Winston-Salem, North Carolina, United States
    Recruiting
  • Ohio State East Hospital
    Columbus, Ohio, United States
    Recruiting
  • OSU Wexner Medical Center
    Columbus, Ohio, United States
    Recruiting
Show 3 more locations
  • Temple University Hospital
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Intermountain Medical Center
    Murray, Utah, United States
    Recruiting
  • Harborview Medical Center
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Henry E Wang, MD, MS — Ohio State University
  • Study coordinator: Henry E Wang, MD, MS
  • Email: Henry.wang@osumc.edu
  • Phone: 614-648-1372

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.